|
US6440421B1
(en)
|
1996-04-18 |
2002-08-27 |
Auchkland Uniservices Limited |
Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
|
|
US5888963A
(en)
*
|
1996-04-18 |
1999-03-30 |
Auckland Uniservices Limited |
Treatment of bone disorders with adrenomedullin
|
|
US6869926B1
(en)
|
1997-09-26 |
2005-03-22 |
Auckland Uniservices Limited |
Therapeutic method
|
|
EP1214600B1
(en)
|
1999-09-10 |
2005-12-21 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Determination of adrenomedullin-binding proteins
|
|
KR100486622B1
(ko)
*
|
2000-11-17 |
2005-05-03 |
차국헌 |
폴리메틸실세스퀴옥산 공중합체와 그 제조방법 및 이를이용한 저유전성 코팅막
|
|
FR2821080B1
(fr)
*
|
2001-02-20 |
2003-12-19 |
Sanofi Synthelabo |
Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques
|
|
US20110087312A1
(en)
*
|
2001-03-02 |
2011-04-14 |
Erchonia Corporatin |
Method for Treatment of Diabetes and Prediabetes with Low-Level Laser Therapy
|
|
JP2005508838A
(ja)
|
2001-03-23 |
2005-04-07 |
アフトン コーポレーション |
膵癌の組合せ治療
|
|
US20090191232A1
(en)
|
2001-05-04 |
2009-07-30 |
Gevas Philip C |
Combination therapy for the treatment of tumors
|
|
CN1753909A
(zh)
*
|
2002-03-19 |
2006-03-29 |
株式会社康福来 |
肽,含有该肽的药物组合物和用于治疗癌症的药物组合物
|
|
US20040127445A1
(en)
*
|
2002-08-28 |
2004-07-01 |
Chondrogene Limited |
Beta-2 microglobulin (B2M) and B2M related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
|
|
CN100434439C
(zh)
*
|
2002-09-30 |
2008-11-19 |
肿瘤疗法科学股份有限公司 |
与人髓细胞白血病相关的基因和多肽
|
|
EP1575417A4
(en)
*
|
2002-09-30 |
2007-07-04 |
Bayer Pharmaceuticals Corp |
CANCER FORECASTING AND PROGNOSTIC TECHNIQUES AND SURVEILLANCE OF ANTICANCER THERAPY
|
|
AU2003282660C1
(en)
|
2002-10-04 |
2009-04-02 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Vasoregulating compounds and methods of their use
|
|
EP1575511A4
(en)
*
|
2002-11-07 |
2006-06-28 |
Us Gov Health & Human Serv |
NEW TARGET FOR ANGIOGENESIS AND ANTI-ANGIOGENESIS THERAPY
|
|
AU2004225437B2
(en)
*
|
2003-03-28 |
2010-05-13 |
Cancer Advances, Inc. |
Gastrin hormone immunoassays
|
|
US7228658B2
(en)
|
2003-08-27 |
2007-06-12 |
Weyerhaeuser Company |
Method of attaching an end seal to manufactured seeds
|
|
CA2788502A1
(en)
*
|
2003-09-08 |
2005-03-24 |
The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services |
Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide
|
|
US8691575B2
(en)
*
|
2003-09-30 |
2014-04-08 |
Weyerhaeuser Nr Company |
General method of classifying plant embryos using a generalized Lorenz-Bayes classifier
|
|
US20050108935A1
(en)
*
|
2003-11-25 |
2005-05-26 |
Edwin Hirahara |
Method and system of manufacturing artificial seed coats
|
|
CA2484533C
(en)
*
|
2003-11-25 |
2008-12-02 |
Weyerhaeuser Company |
Systems and method of embryo delivery for manufactured seeds
|
|
US20050108929A1
(en)
*
|
2003-11-25 |
2005-05-26 |
Edwin Hirahara |
Method and system for creating manufactured seeds
|
|
CA2486289C
(en)
*
|
2003-11-25 |
2008-01-08 |
Weyerhaeuser Company |
Combination end seal and restraint
|
|
US7555865B2
(en)
*
|
2003-11-25 |
2009-07-07 |
Weyerhaeuser Nr Company |
Method and system of manufacturing artificial seed coats
|
|
US7356965B2
(en)
*
|
2003-12-11 |
2008-04-15 |
Weyerhaeuser Co. |
Multi-embryo manufactured seed
|
|
US7591287B2
(en)
*
|
2003-12-18 |
2009-09-22 |
Weyerhaeuser Nr Company |
System and method for filling a seedcoat with a liquid to a selected level
|
|
US7568309B2
(en)
*
|
2004-06-30 |
2009-08-04 |
Weyerhaeuser Nr Company |
Method and system for producing manufactured seeds
|
|
ES2400058T3
(es)
|
2004-09-22 |
2013-04-05 |
Cancer Advances, Inc. |
Anticuerpos monoclonales para progastrina
|
|
CA2518279A1
(en)
*
|
2004-09-27 |
2006-03-27 |
Weyerhaeuser Company |
Manufactured seed having a live end seal coating
|
|
US20060070145A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Carlson William C |
Manufactured seed having a live end seal
|
|
US7547488B2
(en)
*
|
2004-12-15 |
2009-06-16 |
Weyerhaeuser Nr Company |
Oriented strand board panel having improved strand alignment and a method for making the same
|
|
US7654037B2
(en)
*
|
2005-06-30 |
2010-02-02 |
Weyerhaeuser Nr Company |
Method to improve plant somatic embryo germination from manufactured seed
|
|
US8168592B2
(en)
|
2005-10-21 |
2012-05-01 |
Amgen Inc. |
CGRP peptide antagonists and conjugates
|
|
US8906857B2
(en)
*
|
2005-12-01 |
2014-12-09 |
B.R.A.H.M.S. Gmbh |
Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
|
|
US9829494B2
(en)
*
|
2005-12-01 |
2017-11-28 |
Adrenomed Ag |
Methods of treatment using ADM antibodies
|
|
DE102006052916A1
(de)
*
|
2006-11-08 |
2008-05-15 |
Brahms Aktiengesellschaft |
Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM
|
|
AU2008303956A1
(en)
*
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Proadrenomedullin alone or in combination with big gastrin I as a therapeutic agent
|
|
FR2934597B1
(fr)
*
|
2008-07-31 |
2013-04-19 |
Univ Aix Marseille Ii |
Anticorps se liant aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament.
|
|
US20110262939A1
(en)
*
|
2008-10-31 |
2011-10-27 |
B.R.A.H.M.S Gmbh |
Methods and assays for classifying foodstuff and/or beverage and/or diet and/or nutrition regimen and/or medicament in view of an effect on the cardiovascular system
|
|
EP3178835B1
(en)
|
2009-02-03 |
2019-04-10 |
Amunix Pharmaceuticals, Inc. |
Extended recombinant polypeptides and compositions comprising same
|
|
EP2389799A1
(en)
*
|
2010-05-25 |
2011-11-30 |
BioMass Booster, S.L. |
Method for increasing plant biomass
|
|
CN103109192A
(zh)
*
|
2010-06-18 |
2013-05-15 |
塞尚公司 |
用于妊娠性高血压和先兆子痫的预后和风险评估的标志物
|
|
FR2964103B1
(fr)
*
|
2010-08-30 |
2018-11-23 |
Universite D'aix-Marseille |
Anticorps se liant a l'adrenomedulline et aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament
|
|
JP5932279B2
(ja)
*
|
2011-10-07 |
2016-06-08 |
ポーラ化成工業株式会社 |
スクリーニング方法
|
|
US8776012B2
(en)
*
|
2011-10-25 |
2014-07-08 |
International Business Machines Corporation |
Automatic scheduling of review meetings
|
|
JP6336911B2
(ja)
*
|
2011-11-16 |
2018-06-06 |
シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング |
アドレノメジュリンアッセイおよび成熟アドレノメジュリンの測定方法
|
|
PT2780370T
(pt)
|
2011-11-16 |
2019-10-30 |
Adrenomed Ag |
Anticorpo anti-adrenomedulina (adm) ou fragmento anticorpo anti-adm ou estrutura de anticorpo anti-adm não ig para utilização na terapia de uma doença aguda ou condição aguda de um paciente para estabilizar a circulação
|
|
PT2780371T
(pt)
|
2011-11-16 |
2019-01-30 |
Adrenomed Ag |
Anticorpo anti-adrenomedulina (adm) ou fragmento de anticorpo anti-adm ou uma estrutura não ig anti-adm para a regulação do equilíbrio de fluidos num doente com uma doença aguda ou crónica
|
|
SG10201801919QA
(en)
|
2011-11-16 |
2018-04-27 |
Adrenomed Ag |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
|
|
JP5953108B2
(ja)
*
|
2012-05-14 |
2016-07-20 |
ポーラ化成工業株式会社 |
スクリーニング方法
|
|
JP6218084B2
(ja)
|
2012-10-04 |
2017-10-25 |
国立研究開発法人国立循環器病研究センター |
悪性腫瘍転移抑制用医薬
|
|
PL3082858T3
(pl)
*
|
2013-12-20 |
2021-09-27 |
Angiobiomed Gmbh |
Środek wiążący adrenomedulinę do zastosowania w terapii nowotworu
|
|
DK3067093T3
(da)
*
|
2015-03-12 |
2019-11-18 |
Fund Rioja Salud |
Anvendelse af en inhibitor af adrenomedullin til fremstilling af et lægemiddel egnet til forebyggelse og behandling af sygdomme, der reducerer knogletætheden
|
|
US11370822B2
(en)
|
2017-05-26 |
2022-06-28 |
The Governors Of The University Of Alberta |
Self-assembling peptide for activating human mast cells
|
|
AU2018283284B2
(en)
|
2017-06-15 |
2024-05-16 |
Cancer Advances Inc. |
Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
|
|
US12150978B2
(en)
|
2017-06-15 |
2024-11-26 |
Cancer Advances Inc. |
Compositions and methods for preventing tumors and cancer
|
|
EP3438668A1
(en)
*
|
2017-08-04 |
2019-02-06 |
B.R.A.H.M.S GmbH |
Diagnosis and risk stratification of fungal infections
|
|
EP3971573A1
(en)
|
2017-09-13 |
2022-03-23 |
B.R.A.H.M.S GmbH |
Proadrenomedullin as a marker for abnormal platelet levels
|
|
EP3502706A1
(en)
|
2017-12-20 |
2019-06-26 |
B.R.A.H.M.S GmbH |
Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
|
|
EP4058466A1
(en)
|
2019-11-13 |
2022-09-21 |
Amunix Pharmaceuticals, Inc. |
Barcoded xten polypeptides and compositions thereof, and methods for making and using the same
|